Skip to main content

Advertisement

Log in

Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and 18F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. 18F-FDG PET/CT in recurrent thyroid cancer)

  • Head and Neck
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To compare the diagnostic performance of ultrasound, contrast-enhanced computed tomography (CT) and 18F-FDG positron emission tomography (PET)/CT for detecting recurrent differentiated thyroid cancer in the neck.

Methods

Twenty patients who had undergone previous surgery for differentiated thyroid cancer (19 papillary carcinomas; 1 medullary carcinoma) and presented with pathologically proven recurrence in the neck were included. All patients had undergone ultrasound, CT and PET/CT in the 2 months before further surgery. In each patient, ultrasound, CT and PET/CT images were retrospectively reviewed to determine the presence of loco-regional recurrence by level-by-level analysis. Imaging results were correlated with the histological evaluation of the neck dissection as a standard of reference.

Results

Recurrences were found at 52 out of 110 cervical nodal levels surgically explored. The sensitivity, specificity and accuracy were 69.2 %, 89.7 % and 80.0 % for ultrasound; 63.5 %, 94.8 % and 80.0 % for CT; and 53.8 %, 79.3 % and 67.3 % for PET/CT, respectively. ROC analysis revealed higher diagnostic performance with ultrasound than with PET/CT for detecting recurrent tumour.

Conclusions

Although no significant difference was found among the three techniques, the sensitivity and specificity of ultrasound and CT were higher than those of PET/CT for the evaluation of cervical recurrence in patients with differentiated thyroid cancer.

Key Points

Ultrasound, CT and 18 F-FDG PET/CT can all detect recurrent thyroid cancer.

Ultrasound and CT have higher sensitivity and specificity.

Ultrasound, CT and 18 F-FDG PET/CT frequently demonstrated discordant findings

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Johnson NA, Tublin ME (2008) Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology 249:429–444

    Article  PubMed  Google Scholar 

  2. Aygun N (2008) Imaging of recurrent thyroid cancer. Otolaryngol Clin North Am 41:1095–1106

    Article  PubMed  Google Scholar 

  3. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

    Article  PubMed  CAS  Google Scholar 

  4. Lee JH, Lee HK, Lee DH et al (2007) Ultrasonographic findings of a newly detected nodule on the thyroid bed in postoperative patients for thyroid carcinoma: correlation with the results of ultrasonography-guided fine-needle aspiration biopsy. Clin Imaging 31:109–113

    Article  PubMed  Google Scholar 

  5. Vassallo P, Wernecke K, Roos N, Peters PE (1992) Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 183:215–220

    PubMed  CAS  Google Scholar 

  6. Rosário PW, de Faria S, Bicalho L et al (2005) Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 24:1385–1389

    PubMed  Google Scholar 

  7. Sakai O, Curtin HD, Romo LV, Som PM (2000) Lymph node pathology: benign proliferative, lymphoma, and metastatic disease. Radiol Clin North Am 38:979–998

    Article  PubMed  CAS  Google Scholar 

  8. Som PM, Brandwein M, Lidov M, Lawson W, Biller HF (1994) The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings. Am J Neuroradiol 15:1123–1128

    PubMed  CAS  Google Scholar 

  9. van den Brekel MW, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiological criteria. Radiology 177:379–384

    PubMed  Google Scholar 

  10. Nygaard B, Nygaard T, Jensen LI et al (1998) Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function. Acad Radiol 5:409–414

    Article  PubMed  CAS  Google Scholar 

  11. Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H (1997) Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:1342–1348

    Article  PubMed  CAS  Google Scholar 

  12. Jeong HS, Baek CH, Son YI et al (2006) Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol (Oxf) 65:402–407

    Article  Google Scholar 

  13. Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ (2011) Contrast-enhanced 18F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck 33:324–329

    PubMed  Google Scholar 

  14. Nakagawa T, Yamada M, Suzuki Y (2008) 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 49:1053–1059

    Article  PubMed  Google Scholar 

  15. Altenvoerde G, Lerch H, Kuwert T, Matheja P, Schäfers M, Schober O (1998) Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg 383:160–163

    PubMed  CAS  Google Scholar 

  16. Grünwald F, Schomburg A, Bender H et al (1996) Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312–319

    Article  PubMed  Google Scholar 

  17. Mazzaferri EL, Robbins RJ, Spencer CA et al (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441

    Article  PubMed  CAS  Google Scholar 

  18. Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142

    Article  PubMed  Google Scholar 

  19. Sherman SI, Tielens ET, Sostre S, Wharam MD Jr, Ladenson PW (1994) Clinical utility of post treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 78:629–634

    Article  PubMed  CAS  Google Scholar 

  20. Lee DH, Kang WJ, Seo HS et al (2009) Detection of metastatic cervical lymph nodes in recurrent papillary thyroid carcinoma: computed tomography versus positron emission tomography-computed tomography. J Comput Assist Tomogr 33:805–810

    Article  PubMed  Google Scholar 

  21. Choi JW, Lee JH, Baek JH et al (2010) Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol 36:1608–1615

    Article  PubMed  Google Scholar 

  22. Som PM, Curtin HD, Mancuso AA (2000) Imaging-based nodal classification for evaluation of neck metastatic adenopathy. Am J Roentgenol 174:837–844

    CAS  Google Scholar 

  23. Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531–1537

    PubMed  Google Scholar 

  24. Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG (2008) Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 18:411–418

    Article  PubMed  CAS  Google Scholar 

  25. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W (1996) Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468–1472

    PubMed  CAS  Google Scholar 

  26. Ferris RL, Branstetter BF, Nayak JV (2005) Diagnostic utility of positron emission tomography-computed tomography for predicting malignancy in cystic neck masses in adults. Laryngoscope 115:1979–1982

    Article  PubMed  Google Scholar 

  27. Crippa F, Leutner M, Belli F et al (2000) Which kinds of lymph node metastases can FDG PET detect? a clinical study in melanoma. J Nucl Med 41:1491–1494

    PubMed  CAS  Google Scholar 

  28. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18 fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dae Young Yoon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seo, Y.L., Yoon, D.Y., Baek, S. et al. Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and 18F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. 18F-FDG PET/CT in recurrent thyroid cancer). Eur Radiol 22, 2246–2254 (2012). https://doi.org/10.1007/s00330-012-2470-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2470-x

Keywords

Navigation